Pregnant women have long been advised to tread carefully when it comes to medication, but one common painkiller has been at the center of a heated debate: Is paracetamol safe during pregnancy, or could it increase the risk of autism and other developmental issues in children? This question gained national attention when former U.S. President Donald Trump controversially claimed that paracetamol, known as acetaminophen in the U.S., 'is no good' and urged pregnant women to 'fight like hell' to avoid it. But here's where it gets controversial: a groundbreaking new review published in The Lancet Obstetrics, Gynaecology & Women's Health has found no evidence linking paracetamol use during pregnancy to autism, ADHD, or developmental problems in children.
This comprehensive study analyzed 43 high-quality research papers involving hundreds of thousands of women, specifically comparing pregnancies where paracetamol was taken to those where it wasn’t. The researchers used a 'gold-standard' approach by focusing on sibling studies, which allowed them to control for factors like genetics and family environment. They also examined studies with low bias and long-term follow-ups of over five years to ensure accuracy. The results were clear: 'There is no association,' said lead author Professor Asma Khalil, a consultant obstetrician. 'Paracetamol remains a safe option during pregnancy when taken as guided.'
And this is the part most people miss: avoiding paracetamol during pregnancy can actually pose risks. Health experts warn that untreated pain or high fevers in pregnant women can increase the likelihood of miscarriage, premature birth, or developmental issues in babies. This is why major medical organizations in the UK, U.S., and Europe continue to recommend paracetamol as the first-line treatment for pain and fever during pregnancy.
The study’s findings have been widely welcomed by medical professionals, who hope it will ease anxiety among expectant mothers. 'Pregnant women do not need the added stress of questioning whether a common headache remedy could harm their child,' said Professor Grainne McAlonnan of King's College London. Professor Ian Douglas of the London School of Hygiene and Tropical Medicine praised the review for excluding lower-quality studies and accounting for factors like underlying illnesses in mothers.
However, the debate isn’t entirely settled. Some U.S. health officials and experts, including Dr. Andrew Baccarelli of Harvard, have expressed concerns about the potential risks of 'heavy or prolonged' paracetamol use during pregnancy. The U.S. Food and Drug Administration (FDA) has urged caution but maintains that acetaminophen is still the only approved drug for treating fevers in pregnant women. The FDA also notes that a 'causal relationship' between the drug and neurological conditions has not been established.
So, where does this leave us? While the new review provides strong evidence of paracetamol’s safety, it also highlights the complexity of pregnancy health advice. Should we trust the overwhelming scientific consensus, or is there still room for caution? What do you think? Let us know in the comments—we’d love to hear your thoughts on this ongoing debate.
